Dimitri Grigoriadis
Chief Tech/Sci/R&D Officer at NEUROCRINE BIOSCIENCES, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kevin Gorman | M | 66 | 32 years | |
Gary Lyons | M | 73 | 31 years | |
William Rastetter | M | 76 | 14 years | |
Stephen Sherwin | M | 75 | 25 years | |
Johanna Mercier | F | 54 | 3 years | |
Darin Lippoldt | M | 58 | 10 years | |
Christine Poon | F | 71 | 1 years | |
Richard Pops | M | 62 | 26 years | |
Leslie Norwalk | F | 58 | 26 years | |
Shalini Sharp | F | 49 | 4 years | |
George Morrow | M | 72 | 9 years | |
Bill Wilson | M | - | 28 years | |
Jude Onyia | M | 60 | 3 years | |
Todd Tushla | M | - | - | |
David Boyer | M | 44 | 5 years | |
Haig P. Bozigian | M | 66 | 27 years | |
Eiry Roberts | M | 60 | 6 years | |
Matthew Abernethy | M | 44 | 7 years | |
Kyle Gano | M | 50 | 13 years | |
Eric Benevich | M | 58 | 9 years | |
Julie Cooke | F | 57 | 7 years | |
Ingrid Delaet | M | 58 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Errol de Souza | M | 70 | 6 years | |
David-Alexandre C. Gros | M | 51 | - | |
Joseph A. Mollica | M | 83 | 20 years | |
Corinne Nevinny | F | 64 | 14 years | |
W. Thomas Mitchell | M | 77 | 14 years | |
Alfred Sandrock | M | 67 | 5 years | |
Patricia Lady | F | 65 | 2 years | |
Lawrence Steinman | M | 76 | 8 years | |
Scott Struthers | M | 62 | 10 years | |
Paul W. Hawran | M | 71 | 14 years | |
Richard Ranieri | M | 71 | 3 years | |
Margaret E. Valeur-Jensen | M | 67 | - | |
Yun Fei Zhu | M | - | 12 years | |
Stefan Proniuk | M | 53 | 6 years | |
Daljit Singh Aurora | M | 55 | 1 years | |
Joseph M. Fortunak | M | 69 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 7 years |
Michelle Martin | F | - | 5 years | |
Stephen Betz | M | 58 | 6 years | |
Zachary Hornby | M | 45 | 2 years | |
Yang Sai | M | - | 5 years | |
William Mccarthy | M | - | 1 years | |
Ajay Madan | M | 56 | 3 years | |
Niel C. Hoglen | M | - | 2 years | |
Howard Birndorf | M | 74 | 5 years | |
Stefen A. Boehme | M | - | 8 years | |
Chrysa Mineo | F | 59 | 12 years | |
Paula Swain | F | 66 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 9 years |
Robert J. Little | M | 74 | 3 years | |
Christopher Flint O'Brien | M | 67 | 13 years | |
Tim Coughlin | M | 57 | 15 years | |
Wendell Wierenga | M | 76 | 4 years | |
Adrian Adams | M | 73 | 2 years | |
Henry Y. Pan | M | 77 | 5 years | |
John W. Beck | M | 64 | 4 years | |
Malcolm C. Lloyd-Smith | M | 68 | 9 years | |
Thomas J. Joyce | M | 64 | 2 years | |
Ebun Garner | M | 52 | 2 years | |
Peter R. Young | M | 71 |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | 10 years |
Barbara M. Finn | F | - | - | |
Carol A. Baum | F | 65 | 5 years | |
Stephen G. Marcus | M | - | 2 years | |
Brenda Van Vreeswyk | F | - | 6 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 64 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Dimitri Grigoriadis
- Personal Network